PROC News and Press, Procaps Group S.A. From 05/01/23

MIAMI and BARRANQUILLA, Colombia, May 01, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that it will file its Form 20-F and publish its Fu...

2023-04-12 10:03:10 ET Gainers: Altamira Therapeutics ( CYTO ) +74% . Arrowhead Pharmaceuticals ( ARWR ) +11% . Procaps Group ( PROC ) +11% . Tempest Therapeutics ( TPST ) +11% . Meihua International Medical Technologies ( MHUA )...

Latin American healthcare and pharmaceutical firm Procaps ( NASDAQ: PROC ) on Monday reported preliminary FY 2022 revenue estimates that were below consensus. The company also announced a new $5M share buyback program and the planned transition of its current CEO Ruben Minski. PRO...

Reports Preliminary Financial Estimates for Net Revenue and Adjusted EBITDA for Full Year 2022 Realigns Board of Directors to Focus on Profitable Growth Announces $5M+ Share Repurchase Program Commences $15MM Cost Reduction Plan to Improve Margins and Financial Performan...

Procaps ( NASDAQ: PROC ) said Tuesday that it terminated its previously-reported agreement to acquire Grupo Somar. The closing of the acquisition of Grupo Somar was delayed indefinitely after the company was informed by the sellers that a court in Mexico City issued an "...

MIAMI and BARRANQUILLA, Colombia, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the termination of its previously-reported defini...

MIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced that it will present at the 2023 J.P. Morgan Heal...

Healthcare company Procaps Group ( NASDAQ: PROC ) said it does not expect the proposed acquisition of Grupo Somar to close in 2022. PROC had announced the acquisition of the Mexican pharmaceutical company in May, and had said the deal was expected to close in Q4. The sellers h...

MIAMI and BARRANQUILLA, Colo., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announces an update on its previously reported definitive agreement,...

Procaps Group, S.A. (PROC) Q3 2022 Earnings Conference Call November 16, 2022, 04:00 PM ET Company Participants Melissa Angelini - IR, Director Ruben Minski - Founder, Chief Executive Officer and Director Patricio Vargas - Chief Financial Officer Conference...